clarithromycin has been researched along with carfilzomib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allan, JN; Boussi, L; Boyer, A; Coleman, M; Ely, S; Flicker, K; Forsberg, PA; Jayabalan, D; Lakritz, S; Liotta, B; Mark, TM; Niesvizky, R; Pearse, RN; Pekle, KA; Ribadeneyra, D; Rossi, AC | 1 |
1 trial(s) available for clarithromycin and carfilzomib
| Article | Year |
|---|---|
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Female; Humans; Induction Chemotherapy; Lenalidomide; Maintenance Chemotherapy; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Treatment Outcome | 2021 |